277 related articles for article (PubMed ID: 19743876)
1. Novel binding motif of ACTH analogues at the melanocortin receptors.
Yang Y; Hruby VJ; Chen M; Crasto C; Cai M; Harmon CM
Biochemistry; 2009 Oct; 48(41):9775-84. PubMed ID: 19743876
[TBL] [Abstract][Full Text] [Related]
2. γ₂-Melanocyte stimulation hormone (γ₂-MSH) truncation studies results in the cautionary note that γ₂-MSH is not selective for the mouse MC3R over the mouse MC5R.
Joseph CG; Yao H; Scott JW; Sorensen NB; Marnane RN; Mountjoy KG; Haskell-Luevano C
Peptides; 2010 Dec; 31(12):2304-13. PubMed ID: 20833220
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
[TBL] [Abstract][Full Text] [Related]
4. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
5. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
6. Development of potent selective competitive-antagonists of the melanocortin type 2 receptor.
Bouw E; Huisman M; Neggers SJ; Themmen AP; van der Lely AJ; Delhanty PJ
Mol Cell Endocrinol; 2014 Aug; 394(1-2):99-104. PubMed ID: 25017734
[TBL] [Abstract][Full Text] [Related]
7. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
Yang Y; Chen M; Ventro G; Harmon CM
Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.
Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055
[TBL] [Abstract][Full Text] [Related]
9. Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.
Mayorov AV; Cai M; Chandler KB; Petrov RR; Van Scoy AR; Yu Z; Tanaka DK; Trivedi D; Hruby VJ
J Med Chem; 2006 Mar; 49(6):1946-52. PubMed ID: 16539382
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4,D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling.
Chen M; Cai M; Aprahamian CJ; Georgeson KE; Hruby V; Harmon CM; Yang Y
J Biol Chem; 2007 Jul; 282(30):21712-9. PubMed ID: 17545153
[TBL] [Abstract][Full Text] [Related]
12. Contribution of the transmembrane domain 6 of melanocortin-4 receptor to peptide [Pro5, DNal (2')8]-gamma-MSH selectivity.
Chen M; Cai M; McPherson D; Hruby V; Harmon CM; Yang Y
Biochem Pharmacol; 2009 Jan; 77(1):114-24. PubMed ID: 18930713
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.
Mayorov AV; Cai M; Palmer ES; Dedek MM; Cain JP; Van Scoy AR; Tan B; Vagner J; Trivedi D; Hruby VJ
J Med Chem; 2008 Jan; 51(2):187-95. PubMed ID: 18088090
[TBL] [Abstract][Full Text] [Related]
14. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
16. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
[TBL] [Abstract][Full Text] [Related]
17. Structural Insights into Selective Ligand-Receptor Interactions Leading to Receptor Inactivation Utilizing Selective Melanocortin 3 Receptor Antagonists.
Cai M; Marelli UK; Mertz B; Beck JG; Opperer F; Rechenmacher F; Kessler H; Hruby VJ
Biochemistry; 2017 Aug; 56(32):4201-4209. PubMed ID: 28715181
[TBL] [Abstract][Full Text] [Related]
18. Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold.
Ballet S; Mayorov AV; Cai M; Tymecka D; Chandler KB; Palmer ES; Rompaey KV; Misicka A; Tourwé D; Hruby VJ
Bioorg Med Chem Lett; 2007 May; 17(9):2492-8. PubMed ID: 17314042
[TBL] [Abstract][Full Text] [Related]
19. hMRAPa increases αMSH-induced hMC1R and hMC3R functional coupling and hMC4R constitutive activity.
Kay EI; Botha R; Montgomery JM; Mountjoy KG
J Mol Endocrinol; 2013 Apr; 50(2):203-15. PubMed ID: 23296982
[TBL] [Abstract][Full Text] [Related]
20. Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.
Cai M; Mayorov AV; Cabello C; Stankova M; Trivedi D; Hruby VJ
J Med Chem; 2005 Mar; 48(6):1839-48. PubMed ID: 15771429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
